{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T23:56:36Z","timestamp":1780876596829,"version":"3.54.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Transplant Immunology Laboratory of Hospital Universit\u00e1rio Cajuru"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.trim.2018.03.002","type":"journal-article","created":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T12:30:57Z","timestamp":1522067457000},"page":"33-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Complement-fixing donor-specific anti-HLA antibodies and kidney allograft failure"],"prefix":"10.1016","volume":"49","author":[{"given":"Helena B.","family":"Cazarote","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Shimakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana S.","family":"Valdameri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana L.C.","family":"Contieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Q.C.","family":"von Glehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos M.","family":"Aita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle F.","family":"Susin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5388-6384","authenticated-orcid":false,"given":"Vanessa Santos","family":"Sotomaior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Glehn-Ponsirenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2018.03.002_bb0005","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5201098","article-title":"From humoral theory to performant risk stratification in kidney transplantation","volume":"2017","author":"Lefaucheur","year":"2017","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.trim.2018.03.002_bb0010","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1681\/ASN.2016030368","article-title":"Value of donor-specific anti-HLA antibody monitoring and characterization for risk stratification of kidney allograft loss","volume":"28","author":"Viglietti","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2018.03.002_bb0015","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1681\/ASN.2016070797","article-title":"Antibody-mediated rejection due to preexisting versus de novo donor-specific antibodies in kidney allograft recipients","volume":"28","author":"Aubert","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2018.03.002_bb0020","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nri1702","article-title":"Antibody-mediated organ-allograft rejection","volume":"5","author":"Colvin","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.trim.2018.03.002_bb0025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(12)61265-3","article-title":"Antibody-mediated vascular rejection of kidney allografts: A population-based study","volume":"381","author":"Lefaucheur","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.trim.2018.03.002_bb0030","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1111\/j.1600-6143.2012.04070.x","article-title":"Single-center kidney paired donation: the Methodist San Antonio experience","volume":"12","author":"Bingaman","year":"2012","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2018.03.002_bb0035","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trim.2018.03.002_bb0040","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2249.1991.tb02954.x","article-title":"Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection","volume":"86","author":"Feucht","year":"1991","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.trim.2018.03.002_bb0045","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1681\/ASN.V10102208","article-title":"Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries","volume":"10","author":"Collins","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2018.03.002_bb0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/TP.0b013e31821cdf0d","article-title":"Pretransplant IgG subclasses of donor-specific human leukocyte antigen antibodies and development of antibody-mediated rejection","volume":"92","author":"H\u00f6nger","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2018.03.002_bb0055","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1681\/ASN.2014111120","article-title":"IgG donor-specific anti-human HLA antibody subclasses and kidney allograft antibody-mediated injury","volume":"27","author":"Lefaucheur","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2018.03.002_bb0060","series-title":"Fundamental Immunology","first-page":"1047","article-title":"Complement","author":"Speth","year":"2008"},{"key":"10.1016\/j.trim.2018.03.002_bb0065","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trim.2018.03.002_bb0070","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"8","author":"Lefaucheur","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2018.03.002_bb0075","series-title":"Technical Foundation of the C1q Assay and its Clinical Significance for Transplant Outcomes","first-page":"24","author":"Tyan","year":"2013"},{"key":"10.1016\/j.trim.2018.03.002_bb0080","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2018.03.002_bb0085","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1600-6143.2004.00360.x","article-title":"Predicting kidney graft failure by HLA antibodies: a prospective trial","volume":"4","author":"Terasaki","year":"2004","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2018.03.002_bb0090","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.transproceed.2015.12.116","article-title":"Role of pretransplant complement-fixing donor-specific antibodies identified by C1q assay in kidney transplantation","volume":"48","author":"Thammanichanond","year":"2016","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.trim.2018.03.002_bb0095","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.trim.2013.07.002","article-title":"Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?","volume":"29","author":"Crespo","year":"2013","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.trim.2018.03.002_bb0100","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/TP.0b013e318203fd26","article-title":"C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation","volume":"91","author":"Yabu","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2018.03.002_bb0105","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/tri.12873","article-title":"Determining donor-specific antibodies C1q-binding ability improves the prediction of antibody-mediated rejection in HLA-incompatible kidney transplantation","volume":"30","author":"Malheiro","year":"2017","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2018.03.002_bb0110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1399-3046.2011.01599.x","article-title":"Complement-fixing donor-specific antibodies identified by a novel C1q assay are associated with allograft loss","volume":"16","author":"Sutherland","year":"2012","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.trim.2018.03.002_bb0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ki.2015.275","article-title":"The prevalence and clinical significance of C1q-binding donor-specific anti-HLA antibodies early and late after kidney transplantation","volume":"89","author":"Calp-Inal","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.trim.2018.03.002_bb0120","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.humimm.2009.04.019","article-title":"Monitoring and treating posttransplant human leukocyte antigen antibodies","volume":"70","author":"Everly","year":"2009","journal-title":"Hum. Immunol."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327417301806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327417301806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:58:45Z","timestamp":1760810325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327417301806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":24,"alternative-id":["S0966327417301806"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2018.03.002","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement-fixing donor-specific anti-HLA antibodies and kidney allograft failure","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2018.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}